CHEMOMAB LTD.

City:

Tel Aviv

Country:

Israel

Published Applications:

Last publication date:

2023-07-27

Patent Grants:

Last grant date:

2024-06-25

Top Inventors for applications by CHEMOMAB LTD.

These are the the leading inventors for applications assigned to CHEMOMAB LTD.:

Adi MOR 6 Tel Aviv, Israel
Michal SEGAL SALTO 2 Tel Aviv, Israel
Arnon AHARON 2 Tel Aviv, Israel
Neta BARASHI 2 Tel Aviv, Israel

Sharon HASHMUELI 1 Ramot Naftaly, Israel

Recent patent applications by CHEMOMAB LTD.

CHEMOMAB LTD. based in Tel Aviv, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-07-27

US20230235037A1

Chemistry; metallurgy

METHOD OF TREATMENT USING ANTI-CCL24 ANTIBODY

#2 | 2023-06-22

US20230192836A1

Chemistry; metallurgy

CCL24 INHIBITORS IN THE TREATMENT OF COVID-19

#3 | 2022-11-24 ✅ Patent 12,018,074 granted on 2024-06-25

US20220372126A1

Chemistry; metallurgy

Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

#4 | 2020-02-06 ✅ Patent 11,365,246 granted on 2022-06-21

US20200040070A1

Chemistry; metallurgy

Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases

#5 | 2019-05-23 ✅ Patent 10,479,830 granted on 2019-11-19

US20190153088A1

Chemistry; metallurgy

Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

#6 | 2016-12-22 ✅ Patent 10,246,508 granted on 2019-04-02

US20160368979A1

Chemistry; metallurgy

Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

Also check out CHEMOMAB LTD.'s (Tel Aviv, Israel) applicant profile with 4 patent applications submitted.

AssigneeID:

116868 ⎘